Achaogen Inc., of South San Francisco, said it reached a settlement of its claim with the Defense Threat Reduction Agency (DTRA), a division of the U.S. Department of Defense, in which a $7.1 million settlement will be payable to Achaogen related to the company's 2007 contract with DTRA to develop novel antibacterials for the treatment of biodefense pathogens.